Nektar Therapeutics Stock Price (NASDAQ:NKTR)

Add to My Stocks
$83.45 $0.02 (0.02%) NKTR stock closing price Feb 20, 2018 (Closing)
Prev Close* : $83.43
Market Cap:
$13.38B
Day Low: $82.9
52 Week Low: $12.50
Open: $83.55
Volume: -
Day High: $87.45
52 Week High: $99.02
Dividend:
0.00

Latest Stock Market News

Latest Articles

Nektar Therapeutics News - From Partners

NKTR Stockcharts

View NKTR PE ratio, PS ratio stocks charts and compare with peers.
NKTR Chart
Note: Compare Nektar Therapeutics stock price history with the index and industry peers.

Nektar Therapeutics Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
52.27
PB ratio (
price to book ratio
)
427.81

Nektar Therapeutics Returns

ROE
(return on equity)
-344%

Nektar Therapeutics Financial Ratios

Asset Turnover
1.16
Receivables Turnover
32.1
Debt to Equity
2.94
Dividend Yield
0%

NKTR Industry Peers

Company Price Change (%)
Merck Kgaa (MKGAF)103.20.49 (0.47%)
Cspc Pharma (CHPTY)101.080 (0%)
Bayer Ag (BAYRY)30.360.37 (1.2%)
Merck (MRK)54.981.31 (2.33%)
Amgen (AMGN)182.980.57 (0.31%)
Valeant (VRX)18.580.3 (1.59%)
Baxalta (BXLT)46.020.18 (0.39%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Endocyte (ECYT)3.570.39 (12.26%)
ACER THERAPEUTS (ACER)18.120.75 (4.32%)
Tesaro Inc (TSRO)62.32.3 (3.83%)
Pacira Pharma (PCRX)31.251.1 (3.65%)
MediWound (MDWD)4.50.15 (3.45%)
Regulus Therapeutics (RGLS)1.230.03 (2.5%)
BioCryst Pharma (BCRX)5.060.1 (2.02%)
Top gainers from Medical-Drugs industry
* As of Feb 20, 2018
CompanyPriceChange (%)
Catalyst Pharma (CPRX)3.240.19 (5.54%)
Shire (SHPG)126.677.39 (5.51%)
Heron Therapeutics (HRTX)22.51.3 (5.46%)
Synergy Pharma (SGYP)1.920.11 (5.42%)
TherapeuticsMD (TXMD)5.310.27 (4.84%)
Enanta Pharma (ENTA)77.963.62 (4.44%)
Lannett Co (LCI)16.30.75 (4.4%)
Top losers from Medical-Drugs industry
* As of Feb 20, 2018

Nektar Therapeutics Stock News - Partner Headlines

Nektar Therapeutics Financial Statements

income statement20162015201420132012
Net Sales or Revenues165.43M230.78M200.7M148.92M81.19M
Net Income-153.52M-81.17M-53.91M-162.01M-171.85M
Total Operating Expense248.07M226.04M188.65M230.54M191.95M
View Nektar Therapeutics income statement
balance sheet20162015201420132012
Total Assets568.87M502.06M441.62M434.52M497.79M
Total Liabilities480.74M495.63M405.28M524.43M450.77M
Shareholders Equity88.12M6.42M36.33M-89.9M47.01M
View Nektar Therapeutics balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities7.93M-34.7M-116.42M90.58M1.6M
Net Cash from (used by) Operating Activities-117.02M-73.08M-142M-38.52M-129.75M
Increase (Decrease) in Prop Plant And Equipment-6.39M-11.19M-9.97M-4.09M-10.58M
View Nektar Therapeutics cash flow statement

Nektar Therapeutics Stock Message Board

As of last trading day, Nektar Therapeutics stock price was $83.45. The total market value as denoted by $13.38B for Nektar Therapeutics, is the market value of the company's outstanding shares. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Nektar Therapeutics stock analysis.

Demand for a stock decides its stock market price. For example, if more investors want to buy NKTR stock than sell it, then Nektar Therapeutics stock price goes up. Conversely, if more investors wanted to sell NKTR stock than buy it, there would be greater supply than demand, and the stock price would fall. 2,374,269 NKTR shares were traded yesterday, and Nektar Therapeutics stock chart shows that the NKTR stock quote hit a day high of $87.45 and day low of $82.9. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Nektar Therapeutics dividend per share was 0.00 during the last quarter. Nektar Therapeutics stock price history, gives the entire historical data for NKTR stock.